Table 2.
Sample ID | EM rash | Acute LB symptoms | Serology | Under treatment (at time of collection) | Number of identified Borrelia peptides | Peptide sequence |
---|---|---|---|---|---|---|
108838 | Y | Y | Pos | No | 3 | IDTEEAAVK; NAGNFEIIR; VTLSDISTK |
104821 | Y | Y | Pos | No | 2 | AILKTNGDKTLGAAELEK; NNFCLSKSDLEEIR |
790907 | Y | Y | Pos | No | 2 | SNQDNQTLLLSLHQAIAK; LKNSHAELGVAGNGATTDENAQK |
889597 | Y | Y | Pos | Yes (2 days doxycicline) | 2 | GGYLDHVNHAGAKKVILTVPAK LATVNEAEGK |
213567 | Y | Y | Pos | No | 2 | LATVNEAEGK; NDVSEEKPEIK |
453742 | Ya | Ya | Pos | No | 3 | VVILNEATGK; LATVNEAEGK; FVYIGNVDNMGYTINFK; |
463256 | Y | N | Pos | No | 2 | NLSLFTDFYEISMMNAYFIK; QKATGAINAVSGEQIL |
459235 | Y | Y | Pos | Yes (1 day doxycicline) | 2 | SAKEVINNTSTMEK; SSSVDGFVSFKEYKER |
729340 | Y | Y | Pos | No | 1 | FEDAIVLRDK |
310741 | Y | Y | Pos | No | 2 | VNESDLGIKALDEK; FNVEACFPTLIVEK |
The urine was collected before treatment regimen for all patients. All 10 acute patients were verified to be two tier serology positive 3–6 weeks later. Acute Lyme Borreliosis symptoms = joint pain, fatigue, facial palsy, neurological symptoms.
aDeveloped after collection.